510(k) Report

510(k) · Cleared

Cleared

TT101, Models TT 101-1,-2,-3,-4,-5,-6,-7,-8

K061060510(k) TraditionalCleared Jul 3, 200677-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tissue Technologies Holdings, LLC · FRO Dressing, Wound, Drug

Cleared on Jul 3, 2006 as substantially equivalent to K014129 (Johnson & Johnson Medical, Ltd., 2002) after a 77-day review. Its family tree reaches back 3 generations to 1988. 4 later devices descend from it.

Decided
Jul 3, 2006
Review
77 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K881854 (1988). 5 ancestors in all. 4 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1993: 1 other ancestor1991: 1 other ancestor2007: 1 descendant cleared2009: 1 descendant cleared2011: 1 descendant cleared2010: 1 descendant clearedK881854 · Sorbsan Topical Wound Dressing · E.G. Dick & Assoc. · 1988K982597 · Fibrcol Plus Collagen Wound Dressing with Alginate · Johnson & Johnson Medical, Inc. · 1998K014129 · Promogran Matrix Wound Dressing · Johnson & Johnson Medical, Ltd. · 20021990200020102020
Other ancestors, by generationDescendants, by generation 3 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants K014129 · Promogran Matrix Wound Dressing · Johnson & Johnson Medical, Ltd. · 2002K982597 · Fibrcol Plus Collagen Wound Dressing with Alginate · Johnson & Johnson Medical, Inc. · 1998K881854 · Sorbsan Topical Wound Dressing · E.G. Dick & Assoc. · 19880
  1. Root · 3 generations backK881854 Sorbsan Topical Wound DressingE.G. Dick & Assoc. · 1988
  2. 2 generations backK982597 Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc. · 1998
  3. 1 generation backK014129 Promogran Matrix Wound DressingJohnson & Johnson Medical, Ltd. · 2002
  4. This deviceK061060 TT101, Models TT 101-1,-2,-3,-4,-5,-6,-7,-8Tissue Technologies Holdings, LLC · 2006
  5. Descendant · cites it directly · 2 of its ownK070557 MP 719Marine Polymer Technologies, Inc. · 2007
  6. Descendant · 2 generations on · 0 of its ownK111524 MP 719Marine Polymer Technologies, Inc. · 2011
  7. Descendant · 2 generations on · 0 of its ownK102002 TalymedMarine Polymer Technologies · 2010
  8. Descendant · cites it directly · 0 of its ownK081246 TT-102Tissue Technologies Holdings, LLC · 2009

Most influential descendants

Showing 4 of 4 · See all
  • K070557MP 719Marine Polymer Technologies, Inc. · 2007 · cites it directly2descendants
  • K111524MP 719Marine Polymer Technologies, Inc. · 2011 · 2 generations on0descendants
  • K102002TalymedMarine Polymer Technologies · 2010 · 2 generations on0descendants
  • K081246TT-102Tissue Technologies Holdings, LLC · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K881854Sorbsan Topical Wound DressingE.G. Dick & Assoc.1988—
−2K982597Fibrcol Plus Collagen Wound Dressing with AlginateJohnson & Johnson Medical, Inc.1998—
−1K014129Promogran Matrix Wound DressingJohnson & Johnson Medical, Ltd.2002—
0 (this device)K061060TT101, Models TT 101-1,-2,-3,-4,-5,-6,-7,-8Tissue Technologies Holdings, LLC2006—
+1K070557MP 719Marine Polymer Technologies, Inc.2007—
+2K111524MP 719Marine Polymer Technologies, Inc.2011—
+2K102002TalymedMarine Polymer Technologies2010—
+1K081246TT-102Tissue Technologies Holdings, LLC2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200910
201010
201110
FIG. 1 — Lineage of K061060, 1988–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K014129Promogran Matrix Wound Dressing
Summary page 1
…lO1 Wound Care Dressing Substantial Equivalence: TTLO1I Wound Care Dressing is substantially equivalent to: PROMOGRAN Matrix Wound Dressing (K014129) manufactured by Johnson & Johnson Medical Ltd., Gargrave, North Yorkshire, BD23 3RX, United Kingdom…
Johnson & Johnson Medical, Ltd.2002—

Also cleared against K014129: 5 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070557MP 719Marine Polymer Technologies, Inc.20072
K081246TT-102Tissue Technologies Holdings, LLC20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 4.4 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K070557 (Marine Polymer Technologies, Inc., 2007) has gone furthest, with 2 descendants of its own.
  • 5 other devices also cite its predicate K014129.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

The T1101 Wound Care Dressing is indicated for the

management of exuding wounds including:

Diabetic ulcers

Venous ulcers

Ulcers caused by mixed vascular etiologies

Full thickness and partial thickness wounds

Donor sites and other bleeding surface wounds

Abrasions

Traumatic wounds healing by secondary intention

Dehisced surgical wounds

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061060: TT101, Models TT 101-1,-2,-3,-4,-5,-6,-7,-8.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K061060

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026